News DexCom, Inc.

Equities

DXCM

US2521311074

Real-time Estimate Cboe BZX Other stock markets 10:24:47 2024-06-04 am EDT			5-day change	1st Jan Change
116.4 ^USD	+0.97%		-8.61%	-6.19%

01:00pm	Dexcom Wins Access to Dexcom One for 100,000 People Living with Type 2 Diabetes	CI
Jun. 03	Nova Scotia Now Providing Coverage for Dexcom Continuous Glucose Monitoring Systems	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Dexcom Wins Access to Dexcom One for 100,000 People Living With Type 2 Diabetes	07:04am	BU
Dexcom Wins Access to Dexcom One for 100,000 People Living with Type 2 Diabetes	07:00am	CI
Nova Scotia Now Providing Coverage for Dexcom Continuous Glucose Monitoring Systems	Jun. 03	BU
Nova Scotia Now Providing Coverage for Dexcom Continuous Glucose Monitoring Systems	Jun. 03	CI
Redburn Atlantic Initiates DexCom With Neutral Rating, $130 Price Target	May. 30	MT
Dexcom Announces Upcoming Conference Presentation	May. 29	BU
Declaration of Voting Results by DexCom, Inc	May. 24	CI
Declaration of Voting Results by DexCom, Inc	May. 24	CI
Dexcom Launches Innovative New Sensor as Groundbreaking Report Reveals Alarming Rates of Anxiety and Depression in Those With Type 2 Diabetes	May. 20	BU
Bio Conscious Announces Strategic Api Integration with Dexcom That Will Elevate the Current Level of Care for Diabetes Patients in Clinical Settings	May. 16	CI
DexCom : Human Rights Statement	May. 08	PU
Glutality Powered by StrideMD Announces Integration with Dexcom to Enhance Remote Diabetes Care with CGM Technology	Apr. 30	CI
Wall Street: the worst week of 2024 is followed by the best	Apr. 26	CF
Morgan Stanley Adjusts DexCom's Price Target to $132 From $122	Apr. 26	MT
Canaccord Genuity Adjusts Price Target on DexCom to $145 From $144	Apr. 26	MT
Raymond James Adjusts DexCom Price Target to $160 From $151	Apr. 26	MT
Dexcom's profit beats estimates on strong glucose monitor demand	Apr. 25	RE
DexCom, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
DexCom Q1 Non-GAAP Earnings, Revenue Rise; 2024 Revenue Guidance Gains; Shares Fall After Hours	Apr. 25	MT
Transcript : DexCom, Inc., Q1 2024 Earnings Call, Apr 25, 2024	Apr. 25

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

DexCom is still in the running

March 07, 2024 at 04:49 am EST